TTOO
T2 Biosystems, Inc.
2.15
-
0.10
4.44%
1 x 2.13
4 x 2.17
bid
ask
3 @ 04:00 PM
2.24+0.09 (4.19%)
Bearish
51
Bullish
147
sentiment
2.15
day range
2.27
2.15
52 week range
33.20
News
...
T2 Biosystems director sells shares worth $133 | news.google.com • |
T2 Biosystems stock hits 52-week low at $2.26 amid steep decline | news.google.com • |
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients | news.google.com • |
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference | globenewswire.com • |
T2 Biosystems to Attend Upcoming Investor Conferences | globenewswire.com • |
T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript | seekingalpha.com • |
Profile
...
T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-12 | 2024-09 | 0 | N/A | N/A | N/A |
2024-07-29 | 2024-06 | 0 | -0.66 | N/A | N/A |
2024-05-06 | 2024-03 | 0 | -2.66 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -3.45 | N/A | N/A |
2023-08-07 | 2023-06 | 0 | -8 | N/A | N/A |
2023-05-23 | 2023-03 | 0 | -117 | N/A | N/A |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-17 | ADAMS LAURA LEE | Director | 37.00 | Conversion of Exercise of derivative security |
2023-09-14 | BERNARD THIERRY | Director | 7.32K | Conversion of Exercise of derivative security |
2024-05-08 | CR GROUP, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
2023-09-14 | CUMMING JOHN W | Director | 5.26K | Conversion of Exercise of derivative security |
2024-09-12 | ELSBREE DAVID B | Director | 25.00 | Sale |
2024-02-22 | GIBBS MICHAEL TERRENCE | General Counsel | 135.00 | Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Gsa Capital Partners Llp | 40.35K | 284.88K | 0.01% |
Split
...
Split | Date |
---|---|
1 : 100 | 2023-10-13 |
1 : 50 | 2022-10-13 |
This topic has been deleted. Only users with topic management privileges can see it.
-
When FDA????????????????
-
Hey billy Joel don’t you know that poker game James Bond lost it all maybe reference a winning hand
-
Holding from Ca, wouldn’t sold bellow $10
-
What app is this?
-
Volume half billion by end
-
Massive blast coming soon. Whoever sold ill take alll
-
Held, be forties in 15’
-
Any news out today?
-
Back on its way up
-
Monday pre market
-
Too the moon before 8pm
-
Holding for long run
-
I live in Massachusetts I should just go get some insider info 🤪🤪
-
I’m glad I bought back in at .25 ️️
-
Where is the bottom
-
keep going down baby girl
-
Getting back in at .05
-
Any news?
-
T2 Biosystems director sells shares worth $133
news.google.com • -
T2 Biosystems stock hits 52-week low at $2.26 amid steep decline
news.google.com • -
T2 Biosystems to Attend Upcoming Investor Conferences
globenewswire.com • -
T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
globenewswire.com • -
T2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock
globenewswire.com • -
T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
T2 Biosystems Announces First Quarter 2024 Financial Results
globenewswire.com • -
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
globenewswire.com • -
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
globenewswire.com •